Inlybest Axitinib 5mg Tablets: An Overview

Inlybest Axitinib 5mg Tablets, a tyrosine kinase inhibitor, treats advanced renal cell carcinoma (RCC). Axitinib works by blocking specific proteins (VEGFR-1, VEGFR-2, and VEGFR-3) that promote the growth of blood vessels supplying tumors. Consequently, this action inhibits cancer progression.

Usage and Administration

Doctors typically prescribe this medicine for patients who have failed prior systemic therapy. Patients take the medicine orally, usually twice a day. Furthermore, doctors may adjust dosing based on patient tolerance, response, and any adverse effects. Common side effects include hypertension, fatigue, diarrhea, and decreased appetite, which require close monitoring by healthcare professionals.

Manufacturing and Safety

Aprazer Healthcare Pvt Ltd. manufactures Inlybest Axitinib 5mg Tablets. Patients undergoing treatment with Axitinib should have regular blood pressure and liver function checks. Additionally, they should report any unusual symptoms to their doctor immediately.

Availability and PurchaseGenetec Lifesciences makes Inlybest 5mg Tablets available. To place an order or request a quote, contact us directly. We ensure that we source all products from verified and authorized vendors.

Disclaimer

Product information mentioned on this site is for informative purposes only. The product image belongs to its respective company. Genetec Lifesciences acts as a wholesaler and distributor, not a manufacturer. We source our medicines directly from the company or its authorized vendors.